The retinoic acid receptor-related orphan nuclear receptor γ1 (RORγ1): A novel player determinant of insulin sensitivity in morbid obesity

Obesity

Volumn 20, Issue 3, 2012, Pages 488-497

  Tinahones, Francisco J ^a   Moreno Santos, Inmaculada ^a   Vendrell, Joan ^a   Chacon, M R ^a   Garrido Sanchez, Lourdes ^a   García Fuentes, Eduardo ^a   Macias González, Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MESSENGER RNA; ORPHAN NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; RETINOIC ACID RECEPTOR RELATED ORPHAN NUCLEAR RECEPTOR GAMMA 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN DEPENDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MALE; METABOLIC SYNDROME X; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUBCUTANEOUS FAT;

ADIPOCYTES; ADULT; BLOTTING, WESTERN; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; OBESITY, MORBID; PPAR GAMMA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCUTANEOUS FAT;

EID: 84857665826     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.267     Document Type: Article

References (36)

1. Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol 2006;66:606-630.
2. Tsutsumi C, Okuno M, Tannous L et al. Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem 1992;267:1805-1810.
3. Moon HS, Guo DD, Song HH et al. Regulation of adipocyte differentiation by PEGylated all-trans retinoic acid: reduced cytotoxicity and attenuated lipid accumulation. J Nutr Biochem 2007;18:322-331.
4. Boehm MF, Mondon CE, Nadzan AM et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 1997;386:407-410.
5. Stehlin-Gaon C, Willmann D, Zeyer D et al. All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat Struct Biol 2003;10:820-825.
6. Medvedev A, Yan ZH, Hirose T, Giguère V, Jetten AM. Cloning of a cDNA encoding the murine orphan receptor RZR/ROR gamma and characterization of its response element. Gene 1996;181:199-206.
7. Kang HS, Angers M, Beak JY et al. Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. Physiol Genomics 2007;31:281-294.
8. Giguère V, McBroom LD, Flock G. Determinants of target gene specificity for ROR alpha 1: monomeric DNA binding by an orphan nuclear receptor. Mol Cell Biol 1995;15:2517-2526.
9. Austin S, Medvedev A, Yan ZH et al. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells. Cell Growth Differ 1998;9:267-276.
10. Rosen ED. The transcriptional basis of adipocyte development. Prostaglandins Leukot Essent Fatty Acids 2005;73:31-34.
11. Macias-Gonzalez M, Moreno-Santos I, García-Almeida JM, Tinahones FJ, Garcia-Fuentes E. PPARgamma2 protects against obesity by means of a mechanism that mediates insulin resistance. Eur J Clin Invest 2009;39:972-979.
12. Jetten AM. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 2009;7:e003.
13. Mueller E, Drori S, Aiyer A et al. Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms. J Biol Chem 2002;277:41925-41930.
14. Gastaldi G, Russell A, Golay A et al. Upregulation of peroxisome proliferatoractivated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure. Diabetologia 2007;50:2348-2355.
15. Maeda K, Cao H, Kono K et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 2005;1:107-119.
16. Puigserver P, Wu Z, Park CW et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998;92:829-839.
17. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006;4:263-273.
18. Cardona F, Morcillo S, Gonzalo-Marín M et al. Pro12Ala sequence variant of the PPARG gene is associated with postprandial hypertriglyceridemia in non-E3/E3 patients with the metabolic syndrome. Clin Chem 2006;52:1920-1925.
19. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495.
20. Macías M, Escames G, Leon J et al. Calreticulin-melatonin. An unexpected relationship. Eur J Biochem 2003;270:832-840.
21. Gonzalez MM, Samenfeld P, Peräkylä M, Carlberg C. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor. Mol Endocrinol 2003;17:2028-2038.
22. Cousin B, André M, Casteilla L, Pénicaud L. Altered macrophage-like functions of preadipocytes in inflammation and genetic obesity. J Cell Physiol 2001;186:380-386.
23. Stehlin-Gaon C, Willmann D, Zeyer D et al. All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat Struct Biol 2003;10:820-825.
24. Schwarz EJ, Reginato MJ, Shao D, Krakow SL, Lazar MA. Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription. Mol Cell Biol 1997;17:1552-1561.
25. Ziouzenkova O, Orasanu G, Sharlach M et al. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 2007;13:695-702.
26. Yang Q, Graham TE, Mody N et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362.
27. Barendse W, Bunch RJ, Kijas JW, Thomas MB. The effect of genetic variation of the retinoic acid receptor-related orphan receptor C gene on fatness in cattle. Genetics 2007;175:843-853.
28. Fisher RM, Eriksson P, Hoffstedt J et al. Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 2001;44:1268-1273.
29. Laviola L, Perrini S, Cignarelli A et al. Insulin signaling in human visceral and subcutaneous adipose tissue in vivo. Diabetes 2006;55:952-961.
30. Olefsky JM. Treatment of insulin resistance with peroxisome proliferatoractivated receptor gamma agonists. J Clin Invest 2000;106:467-472.
31. Boukhtouche F, Mariani J, Tedgui A. The "CholesteROR" protective pathway in the vascular system. Arterioscler Thromb Vasc Biol 2004;24:637-643.
32. Zizola CF, Schwartz GJ, Vogel S. Cellular retinol-binding protein type III is a PPARgamma target gene and plays a role in lipid metabolism. Am J Physiol Endocrinol Metab 2008;295:E1358-E1368.
33. Lee CH, Olson P, Evans RM. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 2003;144:2201-2207.
34. Molnár F, Matilainen M, Carlberg C. Structural determinants of the agonistindependent association of human peroxisome proliferator-activated receptors with coactivators. J Biol Chem 2005;280:26543-26556.
35. Schwer B, Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metab 2008;7:104-112.
36. Gerhart-Hines Z, Rodgers JT, Bare O et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 2007;26:1913-1923.